MedTrace Logo

Surveillance of Individuals Following SARS-CoV-2 Infection

NCT04383444 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2023-11-01

No results posted yet for this study

Summary

Background:

People who have had contact with a person with a known SARS-CoV-2 infection are being told to self-quarantine for 14 days. This is done to avoid potential virus spread. But the actual time it takes for a person to develop an infection after being exposed to the virus is not well known. The proper quarantine time could be less or more than 2 weeks. Researchers hope this study can be used to help improve public health guidelines for quarantines, social distancing, and returning to work after a possible SARS-CoV-2 exposure.

Objective:

To better understand how long it takes a person to develop (or not develop) an infection with the SARS-CoV-2 virus after they have had contact with a person who has a confirmed infection.

Eligibility:

NIH staff members age 18 and older who had recent contact with a person who has a SARS-CoV-2 infection

Design:

Participants will have 3 study visits at the NIH Clinical Center. They may be asked to have an extra visit depending on the test results at the third visit.

At each visit, participants will give a blood and saliva sample. It will be used to test for SARS-CoV-2 antibodies. Their temperature will be taken. They will complete a short survey to collect data about possible COVID-19 symptoms. At the first visit only, they will also complete a survey that asks about their recent social contacts.

Two types of nasal samples will be collected at each visit. These samples will be tested for the SARS-CoV-2 virus.

1. a swab will be inserted deep into the back of the nose and
2. a swab will be inserted to the middle of your nose.

Participation lasts 3 to 4 weeks.

Conditions

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Steven M Holland, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-07
Primary Completion
2021-03-01
Completion
2022-02-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04383444 on ClinicalTrials.gov